The distribution giant, McKesson Corporation, has agreed to pay the DEA's record fine of $150m after allegedly failing to report “suspicious orders” for controlled substances.
AMRI (Albany Molecular Research Inc.) saw its revenue increase 19% in Q2 compared to the same quarter last year as its discovery services and large scale manufacturing contract revenue spiked by over 20%.
Cardinal Health’s announcement that it is considering spinning off some of its divisions has provoked fevered speculation among industry analysts and media observers alike.
Switzerland's Siegfried Group, a specialist in active
pharmaceutical ingredients (APIs), dosage forms and
biopharmaceuticals, has boosted its position in the production of
controlled substances with the acquisition of US-based...